| Authors | Hackett ML, Anderson CS, House AO. | |
| Title | Management
of depression after stroke: a systematic review of pharmacological therapies. |
|
| Full source | Stroke. 2005 May;36(5):1092-97. | |
|
|
 Per scorrere le diapositive |
|
| Introduction | BACKGROUND
AND PURPOSE: Although depression may affect recovery and outcome after stroke,
it is often overlooked or inadequately managed, and there is uncertainty
regarding the benefits of antidepressant therapy in this setting. We aimed
to assess the effectiveness of antidepressants for the treatment and prevention
of depression after stroke. METHODS: We undertook a systematic review using Cochrane methods of randomized placebo-controlled trials of antidepressants for the treatment or prevention of depressive illness and "abnormal mood" after stroke. Treatment effects on physical and other outcomes were also examined. RESULTS: Outcome data were available for 7 treatment trials including 615 patients and 9 prevention trials including 479 patients. Because of the considerable variation in research design, trial quality, and method of reporting across studies, we did not pool all the outcome data. In the treatment trials, antidepressants reduced mood symptoms but had no clear effect on producing a remission of diagnosable depressive illness. There was no definitive evidence that antidepressants prevent depression or improve recovery after stroke. CONCLUSIONS: There is insufficient randomized evidence to support the routine use of antidepressants for the prevention of depression or to improve recovery from stroke. Although antidepressants may improve mood in stroke patients with depression, it is unclear how clinically significant such modest effects are in patients other than those with major depression. There is a pressing need for further research to better define the role of antidepressants in stroke management. |
|
